Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir for Suppression of Oral HHV-8 Shedding
NCT00194467Phase 2Completed
- Sponsor
- University of Washington
- Start
- Dec 2002
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valganciclovir in human herpesvirus 8 infection, sponsored by University of Washington. Started Dec 2002; status: completed.
02
Drugs
valganciclovir
03
Conditions
human herpesvirus 8 infection
Beyond the preview
Go deeper on NCT00194467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194467.